Vanguard Capital Management’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Sell
1,668,348
-30,967
-2% -$17.6K ﹤0.01% 3503
2026
Q2
$1.5M Buy
1,699,315
+68,226
+4% +$72.4K ﹤0.01% 3501
2026
Q1
$987K Buy
+1,631,089
New +$1.23M ﹤0.01% 3558

Other funds holding PDSB

Vanguard Capital Management's PDSB Position: Q3 2026 in Review

Vanguard Capital Management reduced its PDS Biotechnology (PDSB) stake by 1.8% in Q3 2026, selling an estimated $17.6K and leaving 1,668,348 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

Vanguard Capital Management first reported a position in PDSB in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.5M in Q2 2026. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Vanguard Capital Management held 1,668,348 shares of PDS Biotechnology worth $1.25M as of Q3 2026.
  • Vanguard Capital Management sold 30,967 PDS Biotechnology shares in Q3 2026, an estimated $17.6K.
  • PDS Biotechnology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3503 holding.
  • Vanguard Capital Management first reported a position in PDS Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's PDS Biotechnology position peaked at $1.5M in Q2 2026.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.